Offer - Urjas Oil for just ₹ 1 X
Reclaim L is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
Adult |
|
Geriatric |
|
Is the use of Reclaim L safe for pregnant women?
Reclaim L may cause moderate side effects during pregnancy. If you feel its harmful effects, then stop taking this drug immediately, and do not take Reclaim L again without your doctor's advice.
Is the use of Reclaim L safe during breastfeeding?
Reclaim L can cause moderate side effects on breastfeeding women. If you feel its side effects, then stop taking this drug and consult your doctor. Take this medicine again only if your doctor advises to do so.
What is the effect of Reclaim L on the Kidneys?
Reclaim L rarely affects the kidneys.
What is the effect of Reclaim L on the Liver?
Using Reclaim L does not have any harmful effects on the liver.
What is the effect of Reclaim L on the Heart?
You can take Reclaim L without any fear of damage to the heart.
Reclaim L should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Reclaim L unless your doctor advises you to do so -
Is this Reclaim L habit forming or addictive?
Forming a habit of Reclaim L has not been reported.
Interaction between Food and Reclaim L
Taking Reclaim L with food does not harm your health.
Interaction between Alcohol and Reclaim L
Due to lack of research, nothing can be said about side effects of consuming alcohol while taking Reclaim L .
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Sovaldi® (sofosbuvir)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1149-1150
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 749-750
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Harvoni® (ledipasvir and sofosbuvir)